Results 181 to 190 of about 10,977 (244)

All you need to know about gastrinoma today | Gastrinoma and Zollinger‐Ellison syndrome: A thorough update

Journal of neuroendocrinology, 2023
Zollinger‐Ellison syndrome (ZES) is a distinct syndrome characterized by hyperchlorhydria‐induced peptic ulcer disease and chronic diarrhea. It is the result of a gastrin‐excess state caused by a duodenal or pancreatic neuroendocrine tumor referred to as
Odysseas Chatzipanagiotou   +7 more
semanticscholar   +1 more source

Zollinger-Ellison Syndrome

Medical Clinics of North America, 1991
As clinical experience with patients with ZES has grown, increasing recognition has been made of the broad spectrum of symptoms associated with gastrinomas. Diarrhea and acid-induced esophageal injury have taken their place alongside chronic peptic ulcer disease as indications for screening for gastrinoma.
C L, Berg, M M, Wolfe
openaire   +2 more sources

Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1.

Best practice & research. Clinical endocrinology & metabolism, 2019
About 30% of patients with MEN1 develop a Zollinger-Ellison syndrome. Meanwhile it is well established that the causative gastrinomas are almost exclusively localized in the duodenum and not in the pancreas, MEN1 gastrinomas occur multicentric and are ...
M. Albers, Jerena Manoharan, D. Bartsch
semanticscholar   +1 more source

Zollinger-Ellison syndrome

Current Treatment Options in Gastroenterology, 2003
Zollinger-Ellison syndrome (ZES) is caused by a gastrin-producing tumor called a gastrinoma, which results in gastric acid hypersecretion. Gastrin stimulates the parietal cell to secrete acid directly and indirectly by releasing histamine from enterochromaffin-like (ECL) cells, and induces hyperplasia of parietal and ECL cells.
Patrick D., Hung   +2 more
openaire   +2 more sources

Zollinger-Ellison syndrome

Gastroenterology, 1987
Donald A. Antonioli   +3 more
openaire   +3 more sources

ZOLLINGER-ELLISON SYNDROME

The Lancet, 1964
Few clinical states have aroused more interest and curiosity among physicians than has the Zollinger-Ellison syndrome. In the eight years since its description in 1955, pathologists, physiologists, and clinicians have become very much aware of the intriguing relationship between endocrinopathy and peptic ulceration despite the fact that the syndrome is
openaire   +4 more sources

Zollinger-Ellison syndrome

The American Journal of Surgery, 1969
Abstract Zollinger-Ellison syndrome is caused by a neuroendocrine tumor of the pancreas that secretes gastrin, causing massive gastric acid secretion. Treatment of the acid hypersecretion may be accomplished with pharmacologic acid inhibition. The goal of surgical treatment should be removal of all gross tumor in those without distant metastases ...
William J. Schulte   +4 more
openaire   +3 more sources

Zollinger-Ellison syndrome

Postgraduate Medicine, 1980
The Zollinger-Ellison syndrome (ZES) is characterized by gastrin-producing tumors, gastric acid hypersecretion, peptic ulcers, and diarrhea. ZES may be associated with nonpancreatic endocrine tumors as part of the multiple endocrine adenomatosis-type 1 syndrome.
J B, Marshall, R H, Settles
openaire   +2 more sources

Home - About - Disclaimer - Privacy